Serena Williams is returning to tennis — and bringing the GLP-1 debate with her

Serena Williams is returning to tennis — and bringing the GLP-1 debate with her

The former world No.1 has a partnership with Ro and uses the weight-loss drug Zepbound, which is currently being monitored by WADA. Serena Williams is …

Tennis.com - Stephanie Livaudais • 1h

Read more on tennis.com

  • Serena Williams
  • World Anti-Doping Agency
  • Sports
  • Tennis
  • Women's Sports
Avatar - Tennis.com

Tennis.com flipped this story into Tennis.com•1h

More stories from Serena Williams

See more stories in
Serena Williams

More stories from World Anti-Doping Agency

  • BigBloc Construction Ltd Reports Revenue from Operations of Rs. 283.42 crore in FY26, a rise of 26.2 Percent Y-o-Y
    India

    BigBloc Construction Ltd Reports Revenue from Operations of Rs. 283.42 crore in FY26, a rise of 26.2 Percent Y-o-Y

    newsx.com - NewsX Syndication • 3h

    EBITDA in FY26 stood at Rs. 22.93 crore, reflecting stable performance. Surat (Gujarat) [India], June 1: BigBloc Construction Limited, one of the …

  • Avatar - Indian Express
    Indian Express
    flipped into Indian Express
    NADA finds unused syringes and Russian medicines during checks at wrestling trials
    India

    NADA finds unused syringes and Russian medicines during checks at wrestling trials

    Indian Express - Written by: Pritish Raj • 23h

    Nobody came forward to claim the bag at the men's Asian Games trials in Lucknow, but officials said it belonged to a support staff member Unused …

See more stories in
World Anti-Doping Agency

More stories from Sports

See more stories in
Sports